These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 29794315)

  • 1. [Postoperative Neurological Deficit due to Transient Hypoperfusion in the Pretreated Contralateral Hemisphere after Bypass Surgery in an Adult Patient with Moyamoya Disease:A Case Report].
    Ozaki S; Ohue S; Iwata S; Fukumoto S; Ichikawa H; Onoue S; Inoue A; Nakamura Y; Kohno K
    No Shinkei Geka; 2018 May; 46(5):391-399. PubMed ID: 29794315
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is local hypoperfusion the reason for transient neurological deficits after STA-MCA bypass for moyamoya disease?
    Mukerji N; Cook DJ; Steinberg GK
    J Neurosurg; 2015 Jan; 122(1):90-4. PubMed ID: 25343178
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Delayed intracerebral hemorrhage after superficial temporal artery-middle cerebral artery anastomosis in a patient with moyamoya disease: possible involvement of cerebral hyperperfusion and increased vascular permeability.
    Fujimura M; Shimizu H; Mugikura S; Tominaga T
    Surg Neurol; 2009 Feb; 71(2):223-7; discussion 227. PubMed ID: 18291489
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Temporary neurologic deterioration due to cerebral hyperperfusion after superficial temporal artery-middle cerebral artery anastomosis in patients with adult-onset moyamoya disease.
    Fujimura M; Kaneta T; Mugikura S; Shimizu H; Tominaga T
    Surg Neurol; 2007 Mar; 67(3):273-82. PubMed ID: 17320638
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative analysis of early postoperative cerebral blood flow contributes to the prediction and diagnosis of cerebral hyperperfusion syndrome after revascularization surgery for moyamoya disease.
    Fujimura M; Niizuma K; Endo H; Sato K; Inoue T; Shimizu H; Tominaga T
    Neurol Res; 2015 Feb; 37(2):131-8. PubMed ID: 25082550
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Symptomatic hyperperfusion after superficial temporal artery-middle cerebral artery anastomosis in a child with moyamoya disease.
    Fujimura M; Kaneta T; Shimizu H; Tominaga T
    Childs Nerv Syst; 2007 Oct; 23(10):1195-8. PubMed ID: 17486352
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Seizure following superficial temporal-middle cerebral artery anastomosis in patients with moyamoya disease: possible contribution of postoperative cerebral hyperperfusion].
    Narisawa A; Fujimura M; Shimizu H; Tominaga T
    No Shinkei Geka; 2007 May; 35(5):467-74. PubMed ID: 17491342
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Diagnostic value of perfusion-weighted MRI for evaluating postoperative alteration of cerebral hemodynamics following STA-MCA anastomosis in patients with moyamoya disease].
    Fujimura M; Mugikura S; Shimizu H; Tominaga T
    No Shinkei Geka; 2006 Aug; 34(8):801-9. PubMed ID: 16910493
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Edaravone Reduces Hyperperfusion-Related Neurological Deficits in Adult Moyamoya Disease: Historical Control Study.
    Uchino H; Nakayama N; Kazumata K; Kuroda S; Houkin K
    Stroke; 2016 Jul; 47(7):1930-2. PubMed ID: 27174526
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Recurrent hyperperfusion after revascularization surgery for adult moyamoya disease: a case report].
    Hayashi T; Kashiwazaki D; Akioka N; Kuwayama N; Kuroda S
    No Shinkei Geka; 2014 Jul; 42(7):621-7. PubMed ID: 25006102
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Paradoxical Association of Symptomatic Local Vasogenic Edema with Global Cerebral Hypoperfusion after Direct Revascularization Surgery for Adult Moyamoya Disease.
    Tashiro R; Fujimura M; Mugikura S; Niizuma K; Endo H; Endo T; Tominaga T
    J Stroke Cerebrovasc Dis; 2018 Aug; 27(8):e172-e176. PubMed ID: 29610036
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biphasic Development of Focal Cerebral Hyperperfusion After Revascularization Surgery for Adult Moyamoya Disease Associated With Autosomal Dominant Polycystic Kidney Disease.
    Tashiro R; Fujimura M; Endo H; Endo T; Niizuma K; Tominaga T
    J Stroke Cerebrovasc Dis; 2018 Nov; 27(11):3256-3260. PubMed ID: 30093201
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors of Delayed Hyperperfusion and the Importance of Repeated Cerebral Blood Flow Evaluation for Hyperperfusion After Direct Bypass for Moyamoya Disease.
    Nomura S; Yamaguchi K; Ishikawa T; Kawashima A; Okada Y; Kawamata T
    World Neurosurg; 2018 Oct; 118():e468-e472. PubMed ID: 29990604
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Postoperative Cerebral Ischemia Due to Hypotension in Moyamoya Patient with Autonomic Dysfunction.
    Machida T; Higuchi Y; Nakano S; Ishige S; Shimada J; Honma K
    World Neurosurg; 2018 Jan; 109():204-208. PubMed ID: 28987832
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Perfusion-weighted magnetic resonance imaging used in assessing hemodynamics following superficial temporal artery-middle cerebral artery bypass in patients with Moyamoya disease.
    Li Z; Zhou P; Xiong Z; Ma Z; Wang S; Bian H; Chen J
    Cerebrovasc Dis; 2013; 35(5):455-60. PubMed ID: 23735877
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apparent Diffusion Coefficient and Transient Neurological Deficit after Revascularization Surgery in Moyamoya Disease.
    Araki Y; Takagi Y; Fushimi Y; Arakawa Y; Funaki T; Kikuchi T; Takahashi JC; Togashi K; Miyamoto S
    J Stroke Cerebrovasc Dis; 2015 Sep; 24(9):2054-9. PubMed ID: 26166418
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Local Vasogenic Edema without Cerebral Hyperperfusion after Direct Revascularization Surgery for Moyamoya Disease.
    Sakata H; Fujimura M; Mugikura S; Sato K; Tominaga T
    J Stroke Cerebrovasc Dis; 2015 Jul; 24(7):e179-84. PubMed ID: 25957910
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transient Symptomatic Downregulation of Cortical Neurotransmitter Receptor Function Due to Cerebral Hyperperfusion after Arterial Bypass Surgery for a Patient with Ischemic Moyamoya Disease.
    Shimada Y; Kojima D; Yoshida J; Kobayashi M; Yoshida K; Fujiwara S; Ogasawara K
    Neurol Med Chir (Tokyo); 2018 Nov; 58(11):481-484. PubMed ID: 30369534
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence and risk factors for symptomatic cerebral hyperperfusion after superficial temporal artery-middle cerebral artery anastomosis in patients with moyamoya disease.
    Fujimura M; Mugikura S; Kaneta T; Shimizu H; Tominaga T
    Surg Neurol; 2009 Apr; 71(4):442-7. PubMed ID: 18514264
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Symptomatic cerebral hyperperfusion on SPECT after indirect revascularization surgery for Moyamoya disease.
    Cho WS; Lee HY; Kang HS; Kim JE; Bang JS; Oh CW
    Clin Nucl Med; 2013 Jan; 38(1):44-6. PubMed ID: 23242046
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.